SCHEMBL475436

SCHEMBL475436

CN1C=CCC(C(=O)O)=C1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625984 0.79
SCHEMBL28166842 0.75
SCHEMBL28304546 0.73 ABAT (0.31) NOTUM
SCHEMBL10769457 0.72 TSHR (0.32)
SCHEMBL28744254 0.72 POLB (0.32)
SCHEMBL3040549 0.71
SCHEMBL29217592 0.71
SCHEMBL890924 0.66
SCHEMBL7434280 0.64
SCHEMBL28427720 0.64 TSHR (0.42) NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1038880-B1 Androstanes and pregnanes for allosteric modulation of GABA receptor EURO CELTIQUE SA (LU) 2007-10-17 EP claimed
EP-0837874-B1 NEUROACTIVE STEROIDS OF THE ANDROSTANE AND PREGNANE SERIES EURO CELTIQUE SA (LU) 2004-12-15 EP claimed
EP-0752860-B1 ANDROSTANES AND PREGNANES FOR ALLOSTERIC MODULATION OF GABA RECEPTOR EURO CELTIQUE SA (LU) 2000-08-23 EP claimed
EP-0554436-B1 GABA RECEPTOR MODULATORS EURO CELTIQUE SA (LU) 2000-07-05 EP claimed
EP-0335545-B2 Pharmaceutical formulations for parenteral use UNIV FLORIDA (US) 1998-09-23 EP claimed
EP-0327766-B1 Redox systems for brain-targeted drug delivery UNIV FLORIDA (US) 1998-04-08 EP claimed
WO-1993003721-A1 CHOLECYSTOKININ ANTAGONISTS USEFUL FOR TREATING DEPRESSION WARNER-LAMBERT COMPANY (US) 1993-03-04 WO claimed
EP-0325187-A1 4-alkyl-1, 4-dihydropyridines with PAF-antagonist activity ALTER, S.A. (ES) 1989-07-26 EP claimed
CN-119192266-A 3, 3-Disubstituted 19-norpregnane compounds, compositions, and uses thereof 萨奇治疗股份有限公司 2024-12-27 CN disclosed
CN-111217811-B Fused tricyclic compounds and application thereof in medicines 广东东阳光药业股份有限公司 2024-01-16 CN disclosed
CN-113234114-A 3, 3-disubstituted 19-norpregnane compounds, compositions, and uses thereof 萨奇治疗股份有限公司 2021-08-10 CN disclosed
CN-112996510-A Treatment of chronic traumatic encephalopathy 克泰克有限责任公司 2021-06-18 CN disclosed
CN-108976272-B 3, 3-disubstituted 19-norpregnane compounds, compositions, and uses thereof 萨奇治疗股份有限公司 2021-05-25 CN disclosed
EP-3820471-A1 TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY CTEC LLC (US) 2021-05-19 EP disclosed
EP-0500610-A1 NUCLEOSIDE DERIVATIVES NYCOMED IMAGING AS (NO) 1992-09-02 EP disclosed
WO-1992004038-A1 PRO-DRUGS FOR CCK ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed
WO-1991006554-A1 NUCLEOSIDE DERIVATIVES NYCOMED AS (NO) 1991-05-16 WO disclosed
US-4880816-A Brain-specific delivery of dopamine utilizing dihydropyridine/pyridinium salt-type redox carriers UNIVERSITY OF FLORIDA (US) 1989-11-14 US disclosed
US-4727079-A Brain-specific dopaminergic activity involving dihydropyridine carboxamides, dihydroquinoline and isoquinoline carboxamides UNIVERSITY OF FLORIDA (US) 1988-02-23 US disclosed
US-4622218-A Testicular-specific drug delivery UNIVERSITY OF FLORIDA (US) 1986-11-11 US disclosed